AI assistant
Wockhardt Ltd — Regulatory Filings 2021
Nov 1, 2021
59231_rns_2021-11-01_edcb7dac-d724-4f09-8a88-92dda9a58806.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
1[st] November, 2021
Ref. No.: WOCK/SEC/SE/2021-22/106
==> picture [167 x 46] intentionally omitted <==
BSE Limited Corporate Relations Department P J Towers Dalal Street Mumbai - 400 001
Scrip Code: 532300
National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E) Mumbai - 400 051 NSE Symbol: WOCKPHARMA
Dear Sir/Madam,
Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the Exchanges that a meeting of the Board of Directors of the Company is scheduled to be held on 8[th] November, 2021, inter-alia , to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30[th] September, 2021.
In view of the above, the Trading window for dealing in the Shares of the Company, which was closed from 1[st] October, 2021, shall remain closed till 10[th] November, 2021. Accordingly, the Trading Window shall re-open with effect from 11[th] November, 2021.
Kindly take the above information on record.
Thanking you,
for Wockhardt Limited
==> picture [111 x 53] intentionally omitted <==
Debashis Dey Company Secretary
==> picture [106 x 46] intentionally omitted <==
==> picture [482 x 30] intentionally omitted <==